Understanding OUR Cytokine-Based Immunotherapy Candidates Our Determination extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure solutions remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/ryu-hirayama-joins-lseg-as-country-representative-for-japan/